Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/1996
06/25/1996US5529921 Culturing stable insect cell line capable of assembling antigens and microglobulin proteins into empty complexes, anchoring the empty complexes to the surfaces of cells, culturing, contacting with peptides
06/25/1996US5529915 Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin
06/25/1996US5529914 Photopolymerization of water soluble macromers to form membrane coverings
06/25/1996US5529790 Delayed, sustained-release diltiazem pharmaceutical preparation
06/25/1996US5529784 Burn dressing
06/25/1996US5529770 Viscous liquid conditioning topical germicides
06/25/1996US5529766 Microbubbles comprising protein capable of formation of gas containing microbubbles, protein is crosslinked with crosslinkig grouping contains biodegradable linkages
06/23/1996CA2165890A1 Crosslinked acidic polysaccharides and their uses
06/20/1996WO1996018635A1 Fullerene-oligonucleotide or fullerene-nucleotide conjugates, complexes thereof with nanoparticles, and therapeutical uses thereof
06/20/1996WO1996018421A1 Anticancer drug with a cytostatic and a contrasting agent
06/20/1996WO1996018417A1 Crystalline protein controlled release compositions
06/20/1996WO1996018412A1 Chimeric cytokines and uses thereof
06/20/1996WO1996018411A1 Localized delivery of factors enhancing survival of transplanted cells
06/20/1996WO1996018389A1 Sustained release caffeine formulation
06/20/1996WO1996018388A2 Cross-linked microparticles and their use as therapeutic vehicles
06/20/1996WO1996018387A1 Chewable dosage forms
06/20/1996WO1996018372A2 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
06/20/1996WO1996015234A3 Lipid-splitting enzyme
06/20/1996WO1996013286A3 Modulation of cell proliferation and wound healing
06/20/1996WO1996011675A3 Medicinal and/or nutritional microcapsules for per os administration
06/20/1996WO1996002276A3 Novel polymer gel networks and methods of use
06/20/1996CA2205572A1 Chimeric cytokines and uses thereof
06/20/1996CA2138474A1 Biodegradable injectable drug delivery polymer
06/19/1996EP0716853A1 Sustained release caffeine formulation
06/19/1996EP0716852A1 Pharmaceutical formulations of cefaclor
06/19/1996EP0716648A1 New 9-chloro-prostaglandin derivatives
06/19/1996EP0716610A1 Neural regeneration using human bone morphogenetic proteins
06/19/1996EP0716606A1 Phosphate-binding polymers for oral administration
06/19/1996EP0716599A1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION
06/19/1996EP0716598A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
06/19/1996EP0716595A1 Dispenser containing hydrophobic agent
06/19/1996EP0580817B1 Pharmaceutical formulation and process
06/19/1996EP0578732B1 Chewable antacid compositions
06/19/1996EP0577718B1 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution
06/19/1996CN1124929A Novel agent for controlling cell activity
06/19/1996CN1124925A Lotion
06/18/1996US5527962 Fluoropolymer with perfluoroalkyl mercaptan end group as carrier for drug delivery
06/18/1996US5527928 Cationic transport reagents
06/18/1996US5527904 Humectant, film forming, emulsifier, foam stabilizer, cement mixture
06/18/1996US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies
06/18/1996US5527893 Water insoluble derivatives of polyanionic polysaccharides
06/18/1996US5527890 Derivatives of triterpenoid acids and uses thereof
06/18/1996US5527885 Useful for delivering drugs or radioisotopes to target organs, tumors or thrombi in vivo
06/18/1996US5527864 Capable of crosslinking at body temperature; used as vascular implants
06/18/1996US5527856 Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
06/18/1996US5527832 Antiinflammatory and analgesic transdermal gel
06/18/1996US5527797 Process for transport of agents across the skin and compositions and articles useful therein
06/18/1996US5527783 Dry and Porous galenic form based on plants, its method of preparation and its applications
06/18/1996US5527773 Use of synthetic peptides to disrupt the cytoskeleton
06/18/1996US5527713 Consisting of t-cell specific antibodies covalently bound to amine groups present on water soluble aminodextran
06/18/1996US5527543 A carrier comprising diluent and binder; a film coating comprising a steroid and a lubricant
06/18/1996US5527538 Liposomal targeting of ischemic tissue
06/18/1996US5527537 Contains natural oils, 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine and water
06/18/1996US5527528 Solid-tumor treatment method
06/18/1996US5527527 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
06/18/1996US5527524 Dense star polymer conjugates
06/18/1996US5527523 Hydroquinone amino-acid esters, methods of preparation, and pharmaceutical or cosmetic compositions containing them
06/14/1996CA2158511A1 Pharmaceutical formulations of cefaclor
06/13/1996WO1996018059A1 Functionalized fibrils
06/13/1996WO1996017929A1 Polypeptide with reduced allergenicity
06/13/1996WO1996017925A1 Cytokine designated lerk-7
06/13/1996WO1996017899A1 Anti-oxidant compositions
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017863A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996WO1996017844A1 Novel porphyrins and porphyrin synthesis techniques
06/13/1996WO1996017823A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
06/13/1996WO1996017626A2 Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
06/13/1996WO1996017625A1 Modulating the immune response
06/13/1996WO1996017615A1 Viscous liquid conditioning topical germicides
06/13/1996WO1996017613A1 Hepatic-directed compounds and reagents for preparation thereof
06/13/1996WO1996017611A1 Pharmaceutical composition comprising lamotrigine
06/13/1996WO1996017607A1 Method of producing a pantoprazol lyophilisate
06/13/1996WO1996017603A1 Emulsion suitable for administering a sphingolipid and use thereof
06/13/1996WO1996017597A1 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
06/13/1996WO1996017596A1 Liposomal interferon hybrid compositions
06/13/1996WO1996017595A1 Foamable formulation and foam
06/13/1996WO1996017594A1 Sequestration agents
06/13/1996WO1996017593A1 Solubilisation aids for hydrophilic macromolecules
06/13/1996WO1996017584A2 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
06/13/1996WO1996017580A2 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents
06/13/1996WO1996011021A3 Treatment of tissues to reduce subsequent response to injury
06/13/1996DE19509354A1 Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall Combined preparation for promoting hair growth and possibly the skin and nail growth and to prevent or remedy hair loss
06/13/1996CA2208184A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
06/13/1996CA2208148A1 Novel porphyrins and porphyrin synthesis techniques
06/13/1996CA2207325A1 Anti-oxidant compositions
06/13/1996CA2207292A1 Liposomal interferon hybrid compositions
06/13/1996CA2207284A1 Pharmaceutical composition comprising lamotrigine
06/13/1996CA2207279A1 Solubilisation aids for hydrophilic macromolecules
06/13/1996CA2207274A1 Sequestration agents
06/13/1996CA2207096A1 Hepatic-directed compounds and reagents for preparation thereof
06/13/1996CA2207093A1 Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
06/13/1996CA2207000A1 Modulating the immune response
06/13/1996CA2206852A1 Polypeptide with reduced allergenicity
06/13/1996CA2206488A1 Cytokine designated lerk-7
06/13/1996CA2204738A1 Induction of cytotoxic t-lymphocyte responses
06/12/1996EP0715857A2 Orally applicable pharmaceutical composition containing a water-soluble amino acid as a disintegration accelerator
06/12/1996EP0715856A1 Keratin-storable antifungal composition for external use
06/12/1996EP0715846A1 Pharmaceutical composition for oral administration containing amino acids
06/12/1996EP0715638A1 Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
06/12/1996EP0715637A1 Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
1 ... 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 ... 1712